Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer

Seminars in Radiation Oncology

Volumn 9, Issue 2 SUPPL. 1, 1999, Pages 90-96

  Choy, H ^a   LaPorte, K ^a   Knill Selby, E ^a   Mohr, P ^a   Shyr, Y ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; ESOPHAGITIS; HUMAN; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; RADIATION DOSE; REVIEW;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; ESOPHAGITIS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PACLITAXEL; PROSPECTIVE STUDIES; RADIOTHERAPY; SURVIVAL ANALYSIS;

EID: 0032902222     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)